{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:39:58Z","timestamp":1783208398255,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ajem.2021.07.037","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T02:16:08Z","timestamp":1626920168000},"page":"93-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The impact of antihypertensive use in the treatment of acute ischemic stroke in patients receiving alteplase"],"prefix":"10.1016","volume":"50","author":[{"given":"Megan A.","family":"Rech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Donahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"DeMott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Peksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajem.2021.07.037_bb0005","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ajem.2021.07.037_bb0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ajem.2021.07.037_bb0015","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.07.037_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144260","article-title":"Relationship between blood pressure and outcomes in acute ischemic stroke patients administered lytic medication in the TIMS-China study","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ajem.2021.07.037_bb0025","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/ene.13118","article-title":"Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage","volume":"23","author":"Waltimo","year":"2016","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2021.07.037_bb0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/STROKEAHA.112.681007","article-title":"Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA registry","volume":"44","author":"Endo","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.ajem.2021.07.037_bb0035","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.ajem.2021.07.037_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajem.2006.07.008","article-title":"Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States","volume":"25","author":"Qureshi","year":"2007","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2021.07.037_bb0045","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1161\/STROKEAHA.115.010319","article-title":"Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third international stroke trial of thrombolytic treatment for acute ischemic stroke","volume":"46","author":"Berge","year":"2015","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.ajem.2021.07.037_bb0050","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.002","article-title":"A fall in systolic blood pressure 24 hours after thrombolysis for acute ischemic stroke is associated with early neurological recovery","volume":"25","author":"Gill","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"10.1016\/j.ajem.2021.07.037_bb0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.5811\/westjem.2015.8.27859","article-title":"Outcomes of patients requiring blood pressure control before thrombolysis with tPA for acute ischemic stroke","volume":"16","author":"Darger","year":"2015","journal-title":"West J Emerg Med"},{"issue":"12","key":"10.1016\/j.ajem.2021.07.037_bb0060","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/STROKEAHA.107.510768","article-title":"Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: safe implementation of thrombolysis in stroke-MOnitoring STudy (SITS-MOST)","volume":"39","author":"Wahlgren","year":"2008","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.ajem.2021.07.037_bb0065","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/STROKEAHA.111.645986","article-title":"Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III Trial","volume":"43","author":"de Los Rios la Rosa","year":"2012","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ajem.2021.07.037_bb0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/CPJ.0000000000000085","article-title":"Blood pressure management in stroke: five new things","volume":"4","author":"Bowry","year":"2014","journal-title":"Neurol Clin Pract"},{"issue":"7","key":"10.1016\/j.ajem.2021.07.037_bb0075","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/STROKEAHA.109.548602","article-title":"Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR)","volume":"40","author":"Ahmed","year":"2009","journal-title":"Stroke"},{"issue":"10174","key":"10.1016\/j.ajem.2021.07.037_bb0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(19)30038-8","article-title":"Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial","volume":"393","author":"Anderson","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2021.07.037_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-444-53480-4.00012-6","article-title":"Stroke and diabetes mellitus","volume":"126","author":"Hill","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2021.07.037_bb0090","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1212\/01.wnl.0000229926.85117.75","article-title":"Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy","volume":"67","author":"Martini","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ajem.2021.07.037_bb0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12028-013-9863-9","article-title":"A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke","volume":"19","author":"Liu-DeRyke","year":"2013","journal-title":"Neurocrit Care"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721006033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721006033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:55:50Z","timestamp":1760025350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721006033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":19,"alternative-id":["S0735675721006033"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.07.037","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of antihypertensive use in the treatment of acute ischemic stroke in patients receiving alteplase","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}